What We Do:
The NIDA Genetics Consortium was created in 1999 and has several overarching missions:
- Identify human chromosomal regions containing genes and/or specific genes that confer susceptibility to drug addiction
- Create a repository for data (i.e., clinical information and biospecimens containing DNA) that are contributed by multiple studies, so as to permit pooling of data to maximize statistical power
- Generate a database on molecular genetics of drug use disorders and related phenotypes to provide controlled access for collaborative studies with the broader scientific community
- Establish a consortium of scientists who meet regularly and collaborate on projects
Research Interests:
NIDA has created a list of domains and their associated measures to help with the harmonization of data in the area of genetic studies.
- Genetics Data Harmonization
- NIDA Center For Genetic Studies (cell and DNA biorepository)
- Description of Studies in the NIDA Genetics Consortium
Policies for access and distribution of DNA and clinical data from NIDA-funded studies on the genetics of addiction vulnerability
- Distribution of genetic data and biomaterials from the NIDA Center for Genetic Studies
- NIDA Distribution Agreement
- Frequently Asked Questions About the NIDA Center for Genetic Studies: How to Access the Repository
- Frequently Asked Questions About the NIDA Genetics Consortium and All Human Genetic Studies at NIDA (including information on membership, sharing plans and consent forms)
- Frequently Asked Questions About the NIDA Clinical Trials Network studies within the NIDA Genetics Consortium
Members:
Contact:
Any questions or concerns regarding the Human Genetics Consortium please contact Joni Rutter Ph.D.
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.